NCT07503795Not yet recruiting
Outcomes of Definitive Radiotherapy for Bladder Cancer
Outcomes of Definitive Radiotherapy for Bladder Cancer: Real-World Experience From a Single Center
Source: ClinicalTrials.gov · Last updated 31 Mar 2026
Brief summary (registry, in English)
this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 5 Feb 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Sohag University
- Diseases
- Bladder cancer, Childhood cancers
- NCT number
- NCT07503795
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Apr 2026 to the primary completion date, 1 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.
Who the study is looking for
- Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag university hospitals Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.